View the latest Sight Sciences Inc. (SGHT) stock price, news, historical charts, analyst ratings and financial information from WSJ. On average, Wall Street analysts predict that Sight Sciences's share price could reach $ by Aug 21, The average Sight Sciences stock price prediction. Sight Sciences (SGHT) · Previous Close · $ · ; % · Volume: 36, · Volume % Chg: 74% · Get a Leaderboard Chart for SGHT ·? See How IBD Rates. SGHT. What are your Sight Sciences, Inc. (SGHT) stock predictions? 7 Wall Street analysts have issued ratings. Currently, 2 analysts rated SGHT as Bullish, 0 rated it. Sight Sciences is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Sight Sciences's performance made by.
Sight Sciences Inc (SGHT) ; Price/Sales ; Price/Cash Flow N/A ; Price/Book ; Price/Earnings ttm ; Most Recent Earnings $ on 05/02/ Sight Sciences, Inc. (Nasdaq: SGHT) won a $34 million patent infringement case against Alcon for their Hydrus Microstent in a positive jury trial verdict. The. Get Sight Sciences Inc (SGHT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the. View Sight Sciences (SGHT) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the. Where and when was Sight Sciences incorporated? Sight Sciences, Inc. was incorporated in Delaware in On what stock exchange are Sight Sciences shares. Based on 4 Wall Street analysts offering 12 month price targets for Sight Sciences in the last 3 months. The average price target is $ with a high forecast. Sight Sciences Inc. (SGHT) · Financials · Drug Pipeline · Options · Analyst Ratings · Insider Trades · Device Pipeline · News. On further gains, the stock will meet resistance from the long-term Moving Average at $ On a fall, the stock will find some support from the short-term. Sight Sciences (SGHT) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Sight Sciences/SGHT ; Buy or sell Sight Sciences stock. Stocks, funds and up to % interest earned on uninvested cash. When you invest, your capital is at.
Track Sight Sciences Inc (SGHT) Stock Price, Quote, latest community messages, chart, news and other stock related information. SGHT | Complete Sight Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View Sight Sciences, Inc. SGHT stock quote prices, financial information, real-time forecasts, and company news from CNN. Sight Sciences Inc Share Price · 1 Day + % · 1 Week + % · 1 Month % · 3 Months + % · 6 Months + % · 1 Year + % · 3 Year %. Discover real-time Sight Sciences, Inc. Common Stock (SGHT) stock prices, quotes, historical data, news, and Insights for informed trading and investment. On further gains, the stock will meet resistance from the long-term Moving Average at $ On a fall, the stock will find some support from the short-term. Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates. Sight Sciences (SGHT) delivered earnings and revenue surprises of % and %. Sight Sciences' stock tumbled 32% premarket after revenue warning. MarketWatch Sep 12, am. Trading Information. Previous Close Price: $ Day Range. The stock symbol for Sight Sciences is "SGHT." What Is the Sight Sciences Market Cap? As of today, Sight Sciences market cap is.
MENLO PARK, Calif., Aug. 20, (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Sight Sciences Inc (SGHT) ; Price/Sales ; Price/Cash Flow N/A ; Price/Book ; Price/Earnings ttm ; Most Recent Earnings $ on 05/02/ Sight Sciences Inc. (SGHT) · Financials · Drug Pipeline · Options · Analyst Ratings · Insider Trades · Device Pipeline · News. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the.
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies. Earnings Growth. Earnings for Sight Sciences are expected to grow in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. Sight Sciences Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Sight Sciences Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A.